Notice of Intent to Publish a Request for Applications for Ancillary Studies to Large Ongoing Clinical Projects (R01)

Notice Number: NOT-AR-10-037

Key Dates
Release Date:  June 3, 2010

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), (http://www.niams.gov)

Purpose

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), intends to reissue a Request for Applications (RFA) to solicit applications for Ancillary Studies to Large Ongoing Clinical Projects (http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-10-010.html ). This RFA solicits applications that propose to conduct time-sensitive ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, large, ongoing clinical projects. The ongoing “parent” project can be a large clinical trial or observational study, or a disease registry that can provide a sufficient cohort of well-characterized patients, infrastructure, data, and biological samples. Applications submitted in response to this FOA will undergo an accelerated review and award process. Each application must include a timeline to demonstrate that the parent project has adequate time left to accommodate the proposed ancillary study. In addition, it must justify the time-sensitive nature of the ancillary study and the need for an expedited review and award process. It must also document permission from the parent project to use the patient cohorts, data, and biological materials. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system in the NIAMS portfolio, and thus identify novel targets for diagnosis, treatment, and prevention of disease.

This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The RFA is expected to be published in the Summer of 2010.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Interested parties may contact:

Program Contact:
Yan Wang, M.D., Ph.D.
Division of Skin and Rheumatic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
One Democracy Plaza, Suite 800
6701 Democracy Blvd.
Bethesda, MD 20892-4872
Telephone: (301) 594-5032
Fax: 301-480-1284
Email: [email protected]